RecruitingNot ApplicableNCT05962879

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness


Sponsor

Massachusetts General Hospital

Enrollment

70 participants

Start Date

Mar 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This research study aims to develop a brief group-based treatment called Resilience Training for Teens, then to test how well it protects high school students with mild symptoms of depression, anxiety, or having unusual feelings from developing mental illnesses.


Eligibility

Min Age: 14 YearsMax Age: 19 Years

Inclusion Criteria7

  • Currently enrolled in 9th through 12th grade and between the ages of 14 and 19
  • Endorsed at least one psychotic experience
  • Provided contact information
  • Have a parent or legal guardian who is able and willing to provide written informed consent (if under the age of 18)
  • Have a parent or legal guardian who is able and willing to participate in a parent session
  • Competent and willing to provide written informed assent (if under the age of 18) or consent (if age 18 or older)
  • Able to communicate in English

Exclusion Criteria2

  • Currently prescribed psychotropic medication (not including medications for attention deficit/hyperactivity disorder), regardless of adherence
  • Currently obtaining psychotherapeutic intervention

Interventions

BEHAVIORALResilience Training for Teens

A brief 6-session group-based behavioral intervention for high school aged teenagers at risk of a mental illness.


Locations(1)

Massachusetts General Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05962879


Related Trials